DrugPatentWatch Database Preview
Litigation Details for GLAXO GROUP LIMITED v. KALI LABORATORIES (D.N.J. )
GLAXO GROUP LIMITED v. KALI LABORATORIES (D.N.J. )
| Docket | Start Trial | Date Filed | |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 28:1338 Patent Infringement | Assigned To | |
| Jury Demand | Referred To | ||
| Patents | 4,695,578; 4,753,789; 5,578,628 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in GLAXO GROUP LIMITED v. KALI LABORATORIES
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , and Start Trial .
Details for GLAXO GROUP LIMITED v. KALI LABORATORIES (D.N.J. )
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2005-06-10 | 161 | See U.S. Patent No. 4,695,578, abstract (issued Sept. 22, 1987) [hereinafter “‘578 patent” or “COATES…There are three patents at issue: the first and second “TYERS” patents, i.e., the patents-in- suit; and… ‘789 patent, abstract, col. 1:5, claims 1-3; ‘628 patent, abstract, claim 1. The TYERS patents therefore…and the “COATES” patent, which defendant contends anticipates the TYERS patents. The Court will now …mania. ‘578 patent, cols. 1:19-25, 4:6-21. Of central import to this motion, the COATES patent’s specification | External link to document | |
| 2005-07-27 | 177 | thereof. U.S. Patent No. 4,753,789, claim 1 (issued June 28, 1988) [hereinafter “‘789 patent” or “TYERS … for patent infringement ensued. The patents-in-suit are the so-called “Tyers” patents: TYERS…ondansetron]. U.S. Patent No. 5,578,628, claim 1 (issued Nov. 26, 1996) [hereinafter “‘628 patent” or “TYERS …and vomiting of [ondansetron]. ‘789 patent, claim 1; ‘628 patent, claim 1. The Court accords… relieve nausea and vomiting. ‘789 patent, claim 1; ‘628 patent, claim 1. By their terms, therefore, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
